Skip to content

European Commission approves Holostem project on cell and gene therapy as one of the Important Project of Common European Interest

On the 28th May 2024, European Commission approves Holostem project on cell and gene therapy as one of the Important…

On 22 February 2024, the European Medicines Agency ratified transition of Holoclar from conditional to full Marketing Authorisation

On 22 February 2024, the European Commission ratified, with decision no. 1299 (2024) the passage of the European marketing authorization…

PUBLICATIONS

30 September 2021

Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa

De Rosa L, Enzo E, Zardi G, Bodemer C, Magnoni C, Schneider H, De Luca M. ABSTRACT Epidermolysis bullosa (EB)…

All the Publications
Back To Top